Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
2.160
+0.090 (4.35%)
At close: Aug 21, 2026, 4:00 PM EDT
2.120
-0.040 (-1.85%)
After-hours: Aug 21, 2026, 4:10 PM EDT
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $15.65 million as of August 21, 2026. Its market cap has decreased by -17.61% in one year.
Market Cap
15.65M
Enterprise Value
8.96M
1-Year Change
-17.61%
Ranking
Category
Stock Price
$2.16
ChartMarket Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $15.65M, a decrease of -97.52%. That is a compound annual growth rate of -49.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 15.65M | 54.10% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vyome Holdings | 16.00M |
| Intensity Therapeutics | 15.93M |
| Pasithea Therapeutics | 15.70M |
| KALA BIO | 15.62M |
| Akari Therapeutics, | 15.17M |
| Psyence Biomedical | 14.99M |
| SeaStar Medical Holding | 14.72M |
| BioCardia | 14.64M |